ARTICLE | Finance
Lightstone's first
Lightstone Ventures makes first investment in NCE conjugate play Catabasis
November 18, 2013 8:00 AM UTC
Lightstone Ventures led Catabasis Pharmaceuticals Inc.'s $32.4 million series B round last week, marking the healthcare VC's first investment.
An undisclosed public crossover fund also joined all current investors in the round: SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures (ATV)...